[ RadSafe ] I131 patient during intercontinental flight
Gary H Kramer
Gary_H_Kramer at hc-sc.gc.ca
Mon Feb 9 12:32:45 CST 2009
Greetings
Yes, for sure. Ottawa Airport, Canada.
Regards
Gary
++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++
Dr. Gary H Kramer - Head, National Internal Radiation Assessment Section
National Calibration Reference Centre for Bioasssay and In Vivo Monitoring
Phone: (613) 954 6668 Fax: (613) 960 1372
Mailto: Gary_H_Kramer at hc-sc.gc.ca
http://www.hc-sc.gc.ca/ncrc
++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++
CONFIDENTIALITY
This email, and any attachments, are confidential and also may be
privileged. If you are not the named or intended recipient, or have
otherwise received this communication in error, please delete it from
your in-box, notify the sender immediately, and do not disclose its
content to any other person, use them for any purpose, or store or copy
them in any medium. Thank you for your cooperation.
"Mauro
Campoleoni"
<trentino at iol.it> To
Sent by: "European Radiation Safety Mailing
radsafe-eu-bounce List" <radsafe-eu at fz-juelich.de>,
s at fz-juelich.de <radsafe-d at fz-juelich.de>,
<MEDPHYS-D at strahlentherapie.uni-wue
rzburg.de>, <radsafe at radlab.nl>
09-02-2009 11:13 cc
Moshe Levita
<mlevita at tasmc.health.gov.il>
Please respond to Subject
European Re: [ RadSafe ] I131 patient during
Radiation Safety intercontinental flight
Mailing List
<radsafe-eu at fz-ju
elich.de>
Dear colleagues,
apart the core of the question posted,
I wonder whether anyone of you knows "for sure" that
somewhere there are airport radiation alarm monitors deployed .
Thanks.
Mauro Campoleoni
----------------------------------------------------------------------------
Unità Operativa di Fisica Sanitaria
Fondazione "Ospedale Maggiore Policlinico Mangiagalli e Regina Elena"
Via Pace, 9 20122 - Milano - ITALY
tel. 02-5503.3007
fax 02-5503.5100
----------------------------------------------------------------------------
----- Original Message -----
From: "Hill, Peter" <p.hill at fz-juelich.de>
To: <radsafe-eu at fz-juelich.de>; <radsafe-d at fz-juelich.de>;
<MEDPHYS-D at strahlentherapie.uni-wuerzburg.de>
Cc: "Moshe Levita" <mlevita at tasmc.health.gov.il>
Sent: Monday, February 09, 2009 4:36 PM
Subject: Re: [ RadSafe ] I131 patient during intercontinental flight
Fyi. Moshe Levita is not a member of this list. Please include him in the
To: or Cc: header , in case You should respond. Please note : the
listmanagers will not forward messages. atbw ph
At 09:21 09.02.09, Moshe Levita wrote:
>Dear Colleagues,
>
>
>
>Many Iodine 131 patients arrives in Israel to be treated and then fly back
>home.
>
>The patient stays in the award until the residual dose is below certain
>level.
>
>(Residual activity is calculated by the measurement of dose rate at 1 m)
>
>
>
>I wonder at what residual activity it will be reasonable to allow the
>patient to fly back to his country.
>
>
>
> One have to take into considerations :
>
>
>
>1. Five hours flight of sitting beside another passenger (who might be a
>child or pregnant women)
>
>2. Definite contamination of the airplane toilet, toilet cleaning, toilet
>disposal etc.
>
>3. Possible triggering of airport radiation alarm monitors.
>
>
>
>
>
>
>
>Any suggestion will be welcomed.
>
>
>
>Moshe Levita
>
>Chief Radiation Executive
>
>Ministry of Health
>
>Israel
>_______________________________________________
>You are currently subscribed to the RadSafe mailing list
>
>Before posting a message to RadSafe be sure to have read and understood
the
>RadSafe rules. These can be found at:
>http://radlab.nl/radsafe/radsaferules.html
>
>For information on how to subscribe or unsubscribe and other settings
>visit: http://radlab.nl/radsafe/
============================
Dr. Peter Hill
Forschungszentrum Jülich GmbH
S-B
52425 Jülich
Germany
++49-2461-615081
++49-2461-612166 (FAX)
mailto:p.hill at fz-juelich.de
-------------------------------------------------------------------
-------------------------------------------------------------------
Forschungszentrum Jülich GmbH
52425 Jülich
Sitz der Gesellschaft: Jülich
Eingetragen im Handelsregister des Amtsgerichts Düren Nr. HR B 3498
Vorsitzende des Aufsichtsrats: MinDir'in Bärbel Brumme-Bothe
Geschäftsführung: Prof. Dr. Achim Bachem (Vorsitzender),
Dr. Ulrich Krafft (stellv. Vorsitzender), Prof. Dr. Harald Bolt,
Dr. Sebastian M. Schmidt
-------------------------------------------------------------------
-------------------------------------------------------------------
-------------------------------------------------------------------
-------------------------------------------------------------------
Forschungszentrum Jülich GmbH
52425 Jülich
Sitz der Gesellschaft: Jülich
Eingetragen im Handelsregister des Amtsgerichts Düren Nr. HR B 3498
Vorsitzende des Aufsichtsrats: MinDir'in Bärbel Brumme-Bothe
Geschäftsführung: Prof. Dr. Achim Bachem (Vorsitzender),
Dr. Ulrich Krafft (stellv. Vorsitzender), Prof. Dr. Harald Bolt,
Dr. Sebastian M. Schmidt
-------------------------------------------------------------------
-------------------------------------------------------------------
More information about the RadSafe
mailing list